A trans-Atlantic journey, three robots and some trade secrets all went into the reviving of the childhood favorite. A trans-Atlantic journey, three robots and some ...
Findings showed abemaciclib plus endocrine therapy statistically significantly improved OS vs endocrine therapy alone after 2 years. Topline data were announced from a phase 3 trial evaluating ...
An updated joint position statement on the management of aromatase inhibitor-associated bone loss (AIBL) addresses the heightened fracture risk in women undergoing endocrine therapy for ...
A new research paper was published in Volume 16 of Oncotarget on July 29, 2025, titled "PCAIs stimulate MAPK, PI3K/AKT pathways and ROS-Mediated apoptosis in aromatase inhibitor-resistant breast ...
DEAR DR. ROACH: I am 78 years old. Breast cancer runs in my family, and I am one of the lucky ones who had a lump that was caught early through an annual mammogram. I had a partial mastectomy, which ...
A new research paper was published in Volume 16 of Oncotarget on July 29, 2025, titled "PCAIs stimulate MAPK, PI3K/AKT pathways and ROS-Mediated apoptosis in aromatase inhibitor-resistant breast ...
BUFFALO, NY – August 13, 2025 – A new research paper was published in Volume 16 of Oncotarget on July 29, 2025, titled “PCAIs stimulate MAPK, PI3K/AKT pathways and ROS-Mediated apoptosis in aromatase ...
Dear Dr. Roach: I am 78 years old. Breast cancer runs in my family, and I am one of the lucky ones who had a lump that was caught early through an annual mammogram. I had a partial mastectomy, which ...
The effects of metronomic chemotherapy plus endocrine therapy have yet to be elucidated through a randomized phase III clinical trial. Randomized clinical trials were conducted at 12 centers in China ...
AstraZeneca has produced some fresh data to back up its blockbuster ambitions for camizestrant, tying the oral SERD to a 56% improvement in progression-free survival (PFS) in a phase 3 breast cancer ...
Treatment with an aromatase inhibitor, either alone or in combination with growth hormone (GH), slowed bone advancement and enhanced adult height in mid-pubertal boys with a short predicted adult ...
Camizestrant with a CDK 4/6 inhibitor had a statistically significant and clinically meaningful improvement in PFS in HR+/HER2– advanced breast cancer. Among patients with hormone receptor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback